PRC2 during vertebrate organogenesis: A complex in transition
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
During organogenesis, tissues expand in size and eventually acquire consistent ratios of cells with dazzling diversity in morphology and function. During this process progenitor cells exit the cell cycle and execute differentiation programs through extensive genetic reprogramming that involves the silencing of proliferation genes and the activation of differentiation genes in a step-wise temporal manner. Recent years have witnessed expansion in our understanding of the epigenetic mechanisms that contribute to cellular differentiation and maturation during organ development, as this is a crucial step toward advancing regenerative therapy research for many intractable disorders. Among such epigenetic programs, the developmental roles of the polycomb repressive complex 2 (PRC2), a chromatin remodeling complex that mediates silencing of gene expression, have been under intensive examination. This review summarizes recent findings of how PRC2 functions to regulate the transition from proliferation to differentiation during organogenesis and discusses some aspects of the remaining questions associated with its regulation and mechanisms of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347 · cited 15×
“If tissue differentiation is executed according to an ES cell culture differentiation paradigm, this predicts that tissue-specific inactivation of PRC2 core components during organogenesis should lead to suppression of differentiation and cell fate acquisition (Margueron and Reinberg, 2011).”
BackgroundInfluentialThe complex language of chromatin regulation during transcription
Berger, S. L. (2007) · Nature · doi:10.1038/nature05915 · Cited by 2,768 · cited 6×
“The current view is that under certain signaling conditions, positive- or negative-acting histone PTMs are established on gene promoters which in turn can facilitate recruitment of activators or repressors of gene expression, respectively (Berger, 2007).”
BackgroundInfluentialThe polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717 · cited 2×
“…proliferation and differentiation and is consistent with data from cancer studies where upregulation of Ezh2 has been linked to different types of malignancies, and thus used as a marker for several types of aggressive tumors (Fullgrabe et al., 2011; Kleer et al., 2003; Varambally et al., 2002).”
ResultDriver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724 · cited 2×
“and providing potential avenues for diagnosis and treatment of cancer (Schwartzentruber et al., 2012; Wu et al., 2012).”
BackgroundKleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649 · cited 2×
“…proliferation and differentiation and is consistent with data from cancer studies where upregulation of Ezh2 has been linked to different types of malignancies, and thus used as a marker for several types of aggressive tumors (Fullgrabe et al., 2011; Kleer et al., 2003; Varambally et al., 2002).”
ResultKuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596 · cited 5×
“1) (Kuzmichev et al., 2002; Margueron and Reinberg, 2011).”
BackgroundInfluentialEZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
Shen, X., Liu, Y., Hsu, Y.-J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G.-C., & Orkin, S. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.016 · Cited by 1,021
Ng, S., Johnson, R., & Stanton, L. W. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.459 · Cited by 514
Cited by
Dimitrova, N., Zamudio, J. R., Jong, R. M., Soukup, D., Resnick, R., Sarma, K., Ward, A. J., Raj, A., Lee, J. T., Sharp, P. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.025 · Cited by 445
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
Caganova, M., Carrisi, C., Varano, G., Mainoldi, F., Zanardi, F., Germain, P.-L., George, L., Alberghini, F., Ferrarini, L., Talukder, A. K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70626 · Cited by 258
Auxin production in the endosperm drives seed coat development in Arabidopsis
Figueiredo, D. D., Batista, R. A., Roszak, P. J., Hennig, L., & Köhler, C. (2016) · eLife · doi:10.7554/elife.20542 · Cited by 215
MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells
Peruzzi, P., Bronisz, A., Nowicki, M. O., Wang, Y., Ogawa, D., Price, R., Nakano, I., Kwon, C.-H., Hayes, J., Lawler, S. E., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not055 · Cited by 97
Kennerdell, J. R., Liu, N., & Bonini, N. M. (2018) · Nature Communications · doi:10.1038/s41467-018-06592-5 · Cited by 56
Metadata
- Authors
- Aldiri, I., & Vetter, M. L.
- Venue
- Developmental Biology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 367
- Issue
- 2
- Pages
- 91-99
- ISSN
- 0012-1606 (ISSN-L)
- OpenAlex
- W2074735887
- Cited by
- 55
- References
- 12
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.